Abstract Submission deadline has expired

Abstract Information

ABSTRACT SUBMISSION

Please review the instructions and submit your abstract.

0

Days

Time Remaining until Abstract Deadline

  • All fellows are required to submit abstracts for presentation.
  • All fellows must review ACPE guidelines for CPE.
  • The body of the abstract should be organized as follows:
    • Statement of the purpose
    • Statement of methods used
    • Summary of (preliminary) results to support conclusion
    • Conclusions reached
  • The submission must also include:
    • Two-three learning objectives (see tips on writing objectives)
    • Two-three self-assessment/post-test questions with answers
    • Selection of ACPE topic designator
      • 01: Disease State/Drug therapy
      • 02: New Oncology Therapies/ Novel Mechanisms of Action in Oncology
      • 03: Rare/Orphan Diseases
      • 04: Health Outcomes
      • 05: Patient Safety/Pharmacovigilance/ Drug Safety
      • 06: FDA Trends/Guidances
  • All fellows presenting an abstract must submit a curriculum vitae (CV) with their abstract
  • Abstracts must be submitted ONLINE no later than February 15
  • Remember that conference registration must also be submitted
  • Objectives must be specific and measurable, developed to specifically address the identified educational need, addressed by an active learning activity (case study, Q & A, etc) during the presentation, and covered by a learning assessment / post-test.
  • Please use the one or more of the following verbs when writing your objectives for your presentation: (Use only these verbs).
ArrangeLabelRepeatClassifyListReportDefineLocateReproduceDescribeMemorizeRestateDiscussNameReviewDuplicateOrderSelectExplainOutlineStateExpressRecallTranslateIdentifyRecognizeIndicateRelate
  • Please note: For coordination purposes, you should provide learning objectives on ONLY the Abstract Submission Form, NOT on your slides. Learning objectives and post-test questions will be listed in the program materials.
  • A complete mailing address, phone, and email are required.
  • A Conflict of Interest statement will be completed during the abstract submission process.
  • Short specific titles are desirable. Do NOT use call caps.
  • Authors should be listed with the FIRST NAME FIRST, MIDDLE INITIAL, AND THE LAST NAME LAST; list title and degrees. Place an asterisk by the presenter's name.
  • No tables, graphs, or multiple column text may be included in the abstract.
  • Do not indent or justify paragraphs. Do not use carriage returns except between paragraphs (i.e. leave all line wrap decisions to the word processing program). Do not manually hyphenate words at the end of lines (unless the word is always hyphenated).
  • Check spelling and punctuation carefully. Abstracts will be printed in the abstract book exactly as submitted.
  • Total word count for the body of the abstract is 300 words. This does NOT include title, authors, learning objectives, or self-assessment / post-test questions.
  • For a successful submission of an abstract, it is recommended that you prepare your abstract in a word processing document, have your preceptors review it, and then cut and paste into the online submission form.
  • Disclosure and eliminating bias. Your presentation should be free of any remarks that would show bias. You must place the disclosure information on your first slide. If you have no information to disclose you must specifically state that as well.
    • For example, you may use: "The speaker has no actual or potential conflict of interest in relation to this presentation."
    • Please note: Any speakers WITH a Conflict of Interest to disclose must submit slides by March 27 for peer review. Speakers WITHOUT a Conflict of Interest slides will be due by April 10.
  • You will receive a confirmation number after a successful submission. NO confirmation emails are sent.
  • Failure to comply with abstract requirements may result in an abstract being rejected.

Abstract Submission deadline has expired